Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man

A vote for BCTC

Rita Benko, Lászlo Illényi, Dezsö Kelemen, Robert Papp, András Papp, Loránd Bartho

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Specificity of the effect is a crucial factor in using antagonists for detecting the physiological/pathophysiological roles of receptors. Here we examined the capsaicin receptor antagonist effects of three commercially- available substances, capsazepine, iodo-resiniferatoxin (I-RTX) and BCTC, on isolated smooth muscle preparations, including the human intestine. Care was taken to observe possible non-specific effects, to find out safe and effective concentrations. Capsazepine appeared to have a low margin of safety. I-RTX (up to 1 μM) specifically inhibited capsaicin-induced contractions in the guinea-pig ileum and urinary bladder. I-RTX showed agonist activity on the rat urinary bladder. BCTC (1 μM) abolished the contractile effects of capsaicin (1 or 2 μM) on all preparations tested (guinea-pig ileum, bladder, trachea, as well as rat and mouse bladder), and on the guinea-pig renal pelvis, where it failed to influence capsaicin-sensitive, sensory neuron-mediated positive inotropy in response to field stimulation. On human intestinal preparations BCTC prevented the relaxant effect of capsaicin. It is concluded that of the three antagonists tested BCTC seems the safest one for inhibiting TRPV-1 receptors. The effect of capsazepine may be complicated by non-specific inhibition of smooth muscle contractility and that of I-RTX by agonist activity. The "local efferent" function of capsaicin-sensitive sensory neurons is not influenced by BCTC, as shown by the results obtained in the renal pelvis. In conclusion, of the TRPV-1 receptor antagonists studied, BCTC (1 μM) seems the most reliable in isolated organ experiments. This substance is also effective in the human intestine.

Original languageEnglish
Pages (from-to)44-50
Number of pages7
JournalEuropean Journal of Pharmacology
Volume674
Issue number1
DOIs
Publication statusPublished - Jan 5 2011

Fingerprint

Capsaicin
Smooth Muscle
Urinary Bladder
Guinea Pigs
Kidney Pelvis
Sensory Receptor Cells
Ileum
Intestines
TRPV Cation Channels
Trachea
Safety
iodoresiniferatoxin
capsazepine

Keywords

  • BCTC
  • Capsaicin
  • Capsazepine
  • Human intestine
  • Iodo-resiniferatoxin
  • Smooth muscles
  • TRPV-1 antagonist

ASJC Scopus subject areas

  • Pharmacology

Cite this

Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man : A vote for BCTC. / Benko, Rita; Illényi, Lászlo; Kelemen, Dezsö; Papp, Robert; Papp, András; Bartho, Loránd.

In: European Journal of Pharmacology, Vol. 674, No. 1, 05.01.2011, p. 44-50.

Research output: Contribution to journalArticle

Benko, Rita ; Illényi, Lászlo ; Kelemen, Dezsö ; Papp, Robert ; Papp, András ; Bartho, Loránd. / Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man : A vote for BCTC. In: European Journal of Pharmacology. 2011 ; Vol. 674, No. 1. pp. 44-50.
@article{9efa4a5a197f49f49b6eaac64a12241b,
title = "Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man: A vote for BCTC",
abstract = "Specificity of the effect is a crucial factor in using antagonists for detecting the physiological/pathophysiological roles of receptors. Here we examined the capsaicin receptor antagonist effects of three commercially- available substances, capsazepine, iodo-resiniferatoxin (I-RTX) and BCTC, on isolated smooth muscle preparations, including the human intestine. Care was taken to observe possible non-specific effects, to find out safe and effective concentrations. Capsazepine appeared to have a low margin of safety. I-RTX (up to 1 μM) specifically inhibited capsaicin-induced contractions in the guinea-pig ileum and urinary bladder. I-RTX showed agonist activity on the rat urinary bladder. BCTC (1 μM) abolished the contractile effects of capsaicin (1 or 2 μM) on all preparations tested (guinea-pig ileum, bladder, trachea, as well as rat and mouse bladder), and on the guinea-pig renal pelvis, where it failed to influence capsaicin-sensitive, sensory neuron-mediated positive inotropy in response to field stimulation. On human intestinal preparations BCTC prevented the relaxant effect of capsaicin. It is concluded that of the three antagonists tested BCTC seems the safest one for inhibiting TRPV-1 receptors. The effect of capsazepine may be complicated by non-specific inhibition of smooth muscle contractility and that of I-RTX by agonist activity. The {"}local efferent{"} function of capsaicin-sensitive sensory neurons is not influenced by BCTC, as shown by the results obtained in the renal pelvis. In conclusion, of the TRPV-1 receptor antagonists studied, BCTC (1 μM) seems the most reliable in isolated organ experiments. This substance is also effective in the human intestine.",
keywords = "BCTC, Capsaicin, Capsazepine, Human intestine, Iodo-resiniferatoxin, Smooth muscles, TRPV-1 antagonist",
author = "Rita Benko and L{\'a}szlo Ill{\'e}nyi and Dezs{\"o} Kelemen and Robert Papp and Andr{\'a}s Papp and Lor{\'a}nd Bartho",
year = "2011",
month = "1",
day = "5",
doi = "10.1016/j.ejphar.2011.10.021",
language = "English",
volume = "674",
pages = "44--50",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man

T2 - A vote for BCTC

AU - Benko, Rita

AU - Illényi, Lászlo

AU - Kelemen, Dezsö

AU - Papp, Robert

AU - Papp, András

AU - Bartho, Loránd

PY - 2011/1/5

Y1 - 2011/1/5

N2 - Specificity of the effect is a crucial factor in using antagonists for detecting the physiological/pathophysiological roles of receptors. Here we examined the capsaicin receptor antagonist effects of three commercially- available substances, capsazepine, iodo-resiniferatoxin (I-RTX) and BCTC, on isolated smooth muscle preparations, including the human intestine. Care was taken to observe possible non-specific effects, to find out safe and effective concentrations. Capsazepine appeared to have a low margin of safety. I-RTX (up to 1 μM) specifically inhibited capsaicin-induced contractions in the guinea-pig ileum and urinary bladder. I-RTX showed agonist activity on the rat urinary bladder. BCTC (1 μM) abolished the contractile effects of capsaicin (1 or 2 μM) on all preparations tested (guinea-pig ileum, bladder, trachea, as well as rat and mouse bladder), and on the guinea-pig renal pelvis, where it failed to influence capsaicin-sensitive, sensory neuron-mediated positive inotropy in response to field stimulation. On human intestinal preparations BCTC prevented the relaxant effect of capsaicin. It is concluded that of the three antagonists tested BCTC seems the safest one for inhibiting TRPV-1 receptors. The effect of capsazepine may be complicated by non-specific inhibition of smooth muscle contractility and that of I-RTX by agonist activity. The "local efferent" function of capsaicin-sensitive sensory neurons is not influenced by BCTC, as shown by the results obtained in the renal pelvis. In conclusion, of the TRPV-1 receptor antagonists studied, BCTC (1 μM) seems the most reliable in isolated organ experiments. This substance is also effective in the human intestine.

AB - Specificity of the effect is a crucial factor in using antagonists for detecting the physiological/pathophysiological roles of receptors. Here we examined the capsaicin receptor antagonist effects of three commercially- available substances, capsazepine, iodo-resiniferatoxin (I-RTX) and BCTC, on isolated smooth muscle preparations, including the human intestine. Care was taken to observe possible non-specific effects, to find out safe and effective concentrations. Capsazepine appeared to have a low margin of safety. I-RTX (up to 1 μM) specifically inhibited capsaicin-induced contractions in the guinea-pig ileum and urinary bladder. I-RTX showed agonist activity on the rat urinary bladder. BCTC (1 μM) abolished the contractile effects of capsaicin (1 or 2 μM) on all preparations tested (guinea-pig ileum, bladder, trachea, as well as rat and mouse bladder), and on the guinea-pig renal pelvis, where it failed to influence capsaicin-sensitive, sensory neuron-mediated positive inotropy in response to field stimulation. On human intestinal preparations BCTC prevented the relaxant effect of capsaicin. It is concluded that of the three antagonists tested BCTC seems the safest one for inhibiting TRPV-1 receptors. The effect of capsazepine may be complicated by non-specific inhibition of smooth muscle contractility and that of I-RTX by agonist activity. The "local efferent" function of capsaicin-sensitive sensory neurons is not influenced by BCTC, as shown by the results obtained in the renal pelvis. In conclusion, of the TRPV-1 receptor antagonists studied, BCTC (1 μM) seems the most reliable in isolated organ experiments. This substance is also effective in the human intestine.

KW - BCTC

KW - Capsaicin

KW - Capsazepine

KW - Human intestine

KW - Iodo-resiniferatoxin

KW - Smooth muscles

KW - TRPV-1 antagonist

UR - http://www.scopus.com/inward/record.url?scp=82255183918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82255183918&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2011.10.021

DO - 10.1016/j.ejphar.2011.10.021

M3 - Article

VL - 674

SP - 44

EP - 50

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -